State Street’s Checkmate Pharmaceuticals, Inc. Common Stock CMPI Stock Holding History

State Street’s Portfolio CMPI Stock Details CMPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-11,424	Closed	-$36K	–	5015
2022 Q1	$36K	Buy	11,424 +337	+3%	+$969	﹤0.01%	4846
2021 Q4	$32K	Hold	11,087	–	–	﹤0.01%	4757
2021 Q3	$44K	Buy	+11,087	New	+$57.1K	﹤0.01%	4650
2021 Q2	–	Sell	-83,259	Closed	-$1.01M	–	4507
2021 Q1	$1.01M	Buy	83,259 +24,593	+42%	+$350K	﹤0.01%	3624
2020 Q4	$856K	Buy	58,666 +19,621	+50%	+$250K	﹤0.01%	3585
2020 Q3	$449K	Buy	+39,045	New	+$500K	﹤0.01%	3582

State Street's CMPI Position: Q2 2022 in Review

State Street sold out of Checkmate Pharmaceuticals, Inc. Common Stock (CMPI) in Q2 2022, closing a stake of 11,424 shares — an estimated $36K sold.

State Street first reported a position in CMPI in Q3 2020 and held it in 6 quarters. The position peaked at $1.01M in Q1 2021. 0 funds tracked by Wall St. Rank hold CMPI as of Q2 2022.

State Street reported no remaining Checkmate Pharmaceuticals, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
State Street sold 11,424 Checkmate Pharmaceuticals, Inc. Common Stock shares in Q2 2022, an estimated $36K.
State Street first reported a position in Checkmate Pharmaceuticals, Inc. Common Stock in Q3 2020 and held it in 6 quarters.
State Street's Checkmate Pharmaceuticals, Inc. Common Stock position peaked at $1.01M in Q1 2021.
0 funds tracked by Wall St. Rank held Checkmate Pharmaceuticals, Inc. Common Stock as of Q2 2022.

Based on State Street's 13F filing for Q2 2022, filed 15 Aug 2022.